The Italian Medicines Agency has authorized the Covid 19 Modern Vaccine for the prevention of coronavirus disease 2019 (COVID-19) in individuals aged 18 and over. 

The General Manager is very satisfied, Nicholas Magrini"We enthusiastically welcome the possibility of making a second tool available for this vaccination campaign which is achieving excellent results in Italy. It is a substantially equivalent vaccine compared to the first, with very convincing data for all populations at risk ".

"Science has provided us in a very short time with another very powerful and effective weapon that will certainly immediately affect the health of those most at risk, but also limit the circulation of the virus if, as it is desirable and how it is afflictedly happening, the adherence to the vaccination campaign will be convinced and supported", Said the President of AIFA, George Palu

In the meeting of January 7, 2021, the Technical Scientific Commission of AIFA gave a positive opinion to the dossier, underlining the risk / benefit ratio of the vaccine that is particularly favorable in the population at greater risk, and established the supply regime for marketing.

This is the second COVID-19 vaccine to which the Agency has given the green light, after the Comirnaty one, developed by BioNTech and Pfizer and authorized on December 22, 2020.

Compared to the Comirnaty vaccine, on the basis of currently available data, the safety and efficacy profile of the Moderna vaccine appears substantially overlapping. There are some different characteristics:  

Vaccine information

The Moderna vaccine is indicated from 18 years of age, rather than 16 years of age.
The vaccination schedule provides for two administrations 28 days apart, instead of at least 21 days.
Immunity is considered fully acquired starting 2 weeks after the second administration, rather than one.
The vaccine is stored at temperatures between -15 ° and -25 °, but is stable between + 2 ° and + 8 ° for 30 days if unopened.
The multidose vial contains 6,3 ml and does not require dilution, therefore it is ready for use.

AIFA: "Authorized Modern Vaccine"

| NEWS ', EVIDENCE 2 |